Skip to main content
. 2021 Jun 1;3(1):vdab073. doi: 10.1093/noajnl/vdab073

Figure 2.

Figure 2.

Progression-free survival based on Response Assessment in Neuro-Oncology (RANO) criteria (left) and on clinical criteria (right) in patients treated with PT versus IMRT. IMRT, intensity-modulated radiation therapy; PFS, progression-free survival; PT, proton therapy.